Importance of Dual Induction Tests for Coronary Vasospasm and Ventricular Fibrillation in Patients Surviving
Results OHCA had occurred between midnight and early morning in 10 patients (83%) and VF had been documented as the initial rhythm at cardiac arrest in all patients (Table) . The prevalence of coronary risk factors was relatively low, except for smoking habit (Table) . Bystander cardiopulmonary resuscitation had been performed in 10 patients and therapeutic mild hypothermia in 6 (Table) . The left ventricular ejection fraction was fairly well preserved (66±7%).
All patients were positive for 1 of the 2 tests: coronary spasm alone in 3, VF alone in 2, and both in 7 (Table) . ECG changes typical of Brugada syndrome was induced by pilsicainide in 1 patient with VF alone and in 2 patients with both coronary spasm and VF (Table) . Importantly, 7 of the 10 patients with coronary spasm also had inducible VF, even under intensive medical therapy with CCBs, and all of them had the diffuse type of spasm (Table) .
All patients subsequently underwent ICD implantation. During the follow-up period (1-48 months, mean 19 months), none had chest pain or syncope. However, appropriate ICD shock for VF was documented in 1 patient with both coronary spasm and Brugada syndrome (Figure) .
Discussion
The major finding of the present study is that the patients surviving an OHCA without organic heart diseases were positive for either coronary vasospasm or VF, suggesting heterogeneity of the pathogenesis of OHCA and the importance of performing the induction tests for both of the disorders that could cause OHCA.
The survival rate of OHCA, especially in witnessed cases of VF or pulseless VT, is increasing in association with the decrease in the time interval from ambulance call to electrical shock. 1 Among OHCA survivors, a number of patients have not had apparent structural cardiac abnormalities, indicating a potential role of functional cardiac impairment in the pathogenesis of OHCA. 3 In the present study, all the OHCA survivors were positive for either coronary spasm or VF, and 50% were positive for both tests, indicating the importance of performing both inductions and subsequent medical therapy based on the results of the provocation tests. It remains to be examined in future studies whether coronary microvascular impairment is also involved in patients with both coronary spasm and VF. 5 ICD implantation is a useful therapy for OHCA survivors with induced VF and/or Brugada syndrome diagnosed by EPS, 7 but it is still controversial whether ICD is also effective for secondary prevention of sudden cardiac death caused by coronary spasm. Meisel et al previously reported both the efficacy and limitation of ICD therapy in patients with refractory variant angina. 8 In their 7 patients with variant angina complicated by VF, appropriate ICD shocks were documented in 4 patients, but 1 patient died of electromechanical dissociation even under intensive medical treatment with CCBs. 8 In clinical practice, the efficacy of medication for preventing coronary vasospasm is assessed on the basis of symptoms; however, it is also known that silent myocardial ischemia because of coronary vasospasm can initiate fatal arrhythmias 9 and that coronary vasospasm could be induced despite a fair clinical course with CCBs. 10 Therefore, it remains to be examined in a future multicenter study whether ICD therapy can improve the prognosis of OHCA survivors with coronary vasospasm. In conclusion, it is important that the induction tests for both coronary vasospasm and VF are performed in patients surviving a OHCA without organic heart disease.
